InnovAge (INNV) Q4 2026 Earnings Call Transcript
InnovAge (INNV) reported Q4 2026 revenue of $262.0M, up 18.3% YoY, and net income of $9.8M. Full-year revenue rose 15.9% to $989.7M, with adjusted EBITDA increasing 174.2% to $94.6M. The company guided FY 2027 revenue to $1.05B-$1.085B and adjusted EBITDA to $105M-$115M, citing census growth and rate increases. Management highlighted expansion plans and potential M&A activity, while noting risks from Medicaid rate uncertainties in key states.
How this was made
The 30-second read
Why it matters
The earnings beat and strong guidance suggest operational momentum, but the sizable litigation accrual and Medicaid rate risk introduce volatility.
Market read
First‑time earnings release with fresh guidance for a small‑cap health‑care player; actionable for traders looking at post‑earnings moves.
What to watch
Potential volatility from upcoming V28 risk‑adjustment model transition and state‑level Medicaid negotiations.
Background
InnovAge Holding Corp. (INNV) is a provider of integrated health‑care services for seniors under the PACE model, operating mainly in California, Colorado, and Florida.
Ticker impact
InnovAge reported FY 2026 results with revenue $989.7M, adjusted EBITDA $94.6M and issued FY 2027 guidance, providing fresh earnings data and outlook.
Potential upside of 5‑10% in the next 1‑2 weeks if guidance is well‑received; downside risk if Medicaid rate concerns materialize.
Revenue beat expectations and guidance above consensus, but $52.4M litigation accrual and Medicaid rate risk could temper gains.
Market effects
Positive earnings may lift other value‑based care and PACE providers, reinforcing sector momentum.
California and Colorado health‑care stocks could see modest gains from InnovAge's growth narrative.
Limited; primarily U.S. health‑care sector impact.
Counterpoint
Medicaid rate uncertainty and $52M litigation accrual could lead to earnings miss in FY 2027, pressuring the stock.
Key entities
- ExecutivePatrick Blair
CEO who discussed the company's evolution to "InnovAge 3.0" and future growth strategy.
- ExecutiveBenjamin Adams
CFO who highlighted Medicaid rate risks and provided financial guidance.
